Breaking

Indian YouTuber who documented her travel to Pakistan arrested for allegedly spying
UK pauses trade negotiations with Israel and summons Israeli ambassador
This girl is trying to keep her family alive in Gaza. Hunger already killed her baby niece
South Africa’s Ramaphosa visits Trump for high-stakes talks that could reset or worsen fraught ties
Putin makes first visit to Kursk since Russia claimed to have recaptured the region
Japan’s farm minister resigns over rice gaffe, as stubbornly high prices threaten government’s grip on power
Three children and two adults killed in suicide attack on school bus in Pakistan
Exclusive: Intercepted radio chatter and drone footage appear to capture Russian orders to kill surrendering Ukrainian troops

Business
World News
Investing
Science
Search for:

Investing

First patient dosed in Phase IIb imaging for Brain Mets

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

0

admin

Website

Related Posts

NorthStar Gaming Announces Revocation of Management Cease Trade Order

Lode Gold Leverages Artificial Intelligence to Drive Exploration and Growth in Yukon

TSX Hits Record High Amid Gold Price Surge and Easing Trade Tensions

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (151)
- Investing (604)
- Science (10)
- World News (727)

Disclaimer: investmentintelligencesphere.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts

Copyright © 2025 investmentintelligencesphere.com | All Rights Reserved

Top

Business
World News
Investing
Science

Type above and press Enter to search. Press Esc to cancel.